Is this you? Create Your Porfile
Avatar

Suyu Shu

National Institutes of Health

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Suyu Shu is active.

Explore More

Publication

Featured researches published by Suyu Shu.

Science | 1984

Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2

James J. Mulé; Suyu Shu; Susan L. Schwarz; Steven A. Rosenberg

Journal of Immunology | 1985

The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.

James J. Mulé; Suyu Shu; Steven A. Rosenberg

Journal of Immunology | 1987

Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.

J. J. Mule; J. C. Yang; R. L. Afreniere; Suyu Shu; S. A. Rosenberg

Cancer Research | 1985

Adoptive Immunotherapy of Newly Induced Murine Sarcomas

Suyu Shu; Steven A. Rosenberg

Journal of Immunology | 1987

Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.

Suyu Shu; T. Chou; Steven A. Rosenberg

Journal of Immunology | 1986

The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.

James J. Mulé; James Chih-Hsin Yang; Suyu Shu; Steven A. Rosenberg

Journal of Immunology | 1986

In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells.

Suyu Shu; T. Chou; Steven A. Rosenberg

Cancer Research | 1986

Antitumor Efficacy of Lymphokine-activated Killer Cells and Recombinant Interleukin-2 in Vivo: Survival Benefit and Mechanisms of Tumor Escape in Mice Undergoing Immunotherapy

James J. Mulé; Stephen E. Ettinghausen; Paul J. Spiess; Suyu Shu; Steven A. Rosenberg

Journal of Immunology | 1986

Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression.

L A Matis; Suyu Shu; E S Groves; S Zinn; T Chou; A M Kruisbeek; M Rosenstein; Steven A. Rosenberg

Cancer Research | 1987

In Vitro Differentiation of T-Cells Capable of Mediating the Regression of Established Syngeneic Tumors in Mice

Suyu Shu; Takaaki Chou; Steven A. Rosenberg

Explore More

Collaboration

Dive into the Suyu Shu's collaboration.

Top Co-Authors
Avatar

Steven A. Rosenberg

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Alfred E. Chang

University of Michigan

View shared research outputs
Top Co-Authors
Avatar

James J. Mulé

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Takaaki Chou

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

B. A. Ward

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Donna Perry-Lalley

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

T. Chou

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

E S Groves

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

L A Matis

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Maury Rosenstein

National Institutes of Health

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge